Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

IART, KFED, QLTI, HYGS - Weekend Review For

|Includes:HYGS, Integra LifeSciences Holdings Corporation (IART), QLTI, SMPL




Integra LifeSciences Holdings Corporation (Nasdaq:IART) reported its financial results for the third quarter ending September 30, 2010.

Total revenues for the third quarter were $186.6 million, reflecting an increase of $14.4 million, or 8.3%, over the third quarter of 2009.

Excluding the impact of changes in foreign currency exchange rates, revenues grew 9%.


K-Fed Bancorp (Nasdaq:KFED), the parent company of Kaiser Federal Bank, reported net income of $1.8 million, or $0.13 per diluted share for the quarter ended September 30, 2010. This compares to net income of $1.4 million, or $0.11 per diluted share for the quarter ended September 30, 2009.

The increase in net income resulted from an increase in net interest income and a reduction in the provision for loan losses.


QLT Inc. (Nasdaq:QLTI) reported expansion of the Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber Congenital Amaurosis (LCA) to include patients with Retinitis Pigmentosa (NASDAQ:RP), a set of hereditary retinal diseases demonstrating clinical features similar to LCA.

Both diseases result from genetic mutations of either retinal pigment epithelium protein 65 (RPE65) or lecithin:retinol acyltransferase (LRAT) that are amenable to intervention with QLT091001.

QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.


Hydrogenics Corporation (Nasdaq:HYGS) a leading developer and manufacturer of hydrogen generation and fuel cell products, reported that it will host a conference call at 10:00 a.m. Eastern on November 10, 2010 for the third quarter ended September 30, 2010







Sign-Up For Free Stock Alerts At


business Card 3



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.